# SAB Biotherapeutics, Inc.: Form DEF 14A, filed Dec 18, 2023

- Company: [SAB Biotherapeutics, Inc.](/companies/sabs.md) (CIK 1833214)
- Form: DEF 14A
- Filed: 2023-12-18
- Accepted by EDGAR: Dec 18, 2023, 14:34 ET
- Period: 2023-12-18
- Accession: 0000950170-23-070950
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1833214/000095017023070950/def14a_2024reversesplits.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1833214/000095017023070950/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1833214/000095017023070950/def14a_2024reversesplits.htm

Filed Dec 18, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-070950. Last ingested by Listed: Oct 24, 2026, 14:57 ET. No prices; not investment advice.